Roy R. Teller

Array ( [id] => 584223 [patent_doc_number] => 07442524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'Factor VII or VIIa-like molecules' [patent_app_type] => utility [patent_app_number] => 11/423662 [patent_app_country] => US [patent_app_date] => 2006-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29259 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442524.pdf [firstpage_image] =>[orig_patent_app_number] => 11423662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6593529 [patent_doc_number] => 20100048464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same' [patent_app_type] => utility [patent_app_number] => 11/921797 [patent_app_country] => US [patent_app_date] => 2006-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10712 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048464.pdf [firstpage_image] =>[orig_patent_app_number] => 11921797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120565 [patent_doc_number] => 20070142280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Factor VII or VIIa-like molecules' [patent_app_type] => utility [patent_app_number] => 11/448143 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29154 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142280.pdf [firstpage_image] =>[orig_patent_app_number] => 11448143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 903617 [patent_doc_number] => 07335726 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Lipopeptide stereoisomers, methods for preparing same and useful intermediates' [patent_app_type] => utility [patent_app_number] => 11/448066 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13423 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335726.pdf [firstpage_image] =>[orig_patent_app_number] => 11448066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004981 [patent_doc_number] => 20070202551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'TGFBeta' [patent_app_type] => utility [patent_app_number] => 11/421964 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15242 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202551.pdf [firstpage_image] =>[orig_patent_app_number] => 11421964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9530161 [patent_doc_number] => 08754032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'Concomitant pharmaceutical agents and use thereof' [patent_app_type] => utility [patent_app_number] => 11/916356 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9357 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11916356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889860 [patent_doc_number] => 20060276407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Methods of treating hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/444109 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 48851 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276407.pdf [firstpage_image] =>[orig_patent_app_number] => 11444109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242856 [patent_doc_number] => 20070021351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor' [patent_app_type] => utility [patent_app_number] => 11/444055 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 49181 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021351.pdf [firstpage_image] =>[orig_patent_app_number] => 11444055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142419 [patent_doc_number] => 20070004635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Method of treating interferon non-responders using HCV protease inhibitor' [patent_app_type] => utility [patent_app_number] => 11/443868 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34003 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004635.pdf [firstpage_image] =>[orig_patent_app_number] => 11443868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889845 [patent_doc_number] => 20060276405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Methods for treating hepatitis C' [patent_app_type] => utility [patent_app_number] => 11/443923 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35885 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276405.pdf [firstpage_image] =>[orig_patent_app_number] => 11443923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887834 [patent_doc_number] => 20060275366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Controlled-release formulation' [patent_app_type] => utility [patent_app_number] => 11/443905 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 45936 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275366.pdf [firstpage_image] =>[orig_patent_app_number] => 11443905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889840 [patent_doc_number] => 20060276404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Medicaments and methods combining a HCV protease inhibitor and an AKR competitor' [patent_app_type] => utility [patent_app_number] => 11/443647 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 44666 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276404.pdf [firstpage_image] =>[orig_patent_app_number] => 11443647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889851 [patent_doc_number] => 20060276406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Methods of treating hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/443959 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 46488 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276406.pdf [firstpage_image] =>[orig_patent_app_number] => 11443959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774219 [patent_doc_number] => 08119602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Administration of HCV protease inhibitors in combination with food to improve bioavailability' [patent_app_type] => utility [patent_app_number] => 11/443793 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 43015 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119602.pdf [firstpage_image] =>[orig_patent_app_number] => 11443793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995086 [patent_doc_number] => 20070010431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Pharmaceutical formulations and methods of treatment using the same' [patent_app_type] => utility [patent_app_number] => 11/444078 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32395 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010431.pdf [firstpage_image] =>[orig_patent_app_number] => 11444078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5010517 [patent_doc_number] => 20070280996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Dietary supplement having improved efficacy at time of consumption' [patent_app_type] => utility [patent_app_number] => 11/443656 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2156 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280996.pdf [firstpage_image] =>[orig_patent_app_number] => 11443656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81761 [patent_doc_number] => 07745390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Antimicrobial peptides' [patent_app_type] => utility [patent_app_number] => 11/438563 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14471 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745390.pdf [firstpage_image] =>[orig_patent_app_number] => 11438563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53157 [patent_doc_number] => 07772177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'BIR domain binding compounds' [patent_app_type] => utility [patent_app_number] => 11/434166 [patent_app_country] => US [patent_app_date] => 2006-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32920 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772177.pdf [firstpage_image] =>[orig_patent_app_number] => 11434166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374682 [patent_doc_number] => 20090312243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) WITH ANTI-ANGIOGENIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/914380 [patent_app_country] => US [patent_app_date] => 2006-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11900 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312243.pdf [firstpage_image] =>[orig_patent_app_number] => 11914380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328827 [patent_doc_number] => 08236927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Stabilizer molecule-depleted albumin solution' [patent_app_type] => utility [patent_app_number] => 11/920015 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 9558 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11920015 [rel_patent_id] =>[rel_patent_doc_number] =>)